Contact Information: For further information contact: David Carey Lazar Partners Ltd. 212-867-1768
Electro-Optical Sciences Announces Participation at the Cowen and Company 29th Annual Health Care Conference
| Source: Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - March 9, 2009) - Electro-Optical Sciences, Inc. ("EOS")
(NASDAQ : MELA ), a medical device company focused on the design and
development of MelaFind®, a
non-invasive, point-of-care instrument to assist in the early detection of
melanoma, today announced that Joseph V. Gulfo, MD, president and chief
executive officer, will present at the Cowen and Company 29th Annual Health
Care Conference taking place at the Boston Marriott Copley Place on March
16 - 19, 2009.
Dr. Gulfo's presentation is scheduled for Monday, March 16 at 2:25pm ET. To
access the live webcast of this presentation, visit www.eosciences.com. A
replay of this presentation will be available on the company's website for
thirty days following the presentation.
About Electro-Optical Sciences
EOS is a medical device company focused on designing and developing a
non-invasive, point-of-care instrument to assist in the early detection of
melanoma. MelaFind features a hand-held imaging device that emits light of
multiple wavelengths to capture images of suspicious pigmented skin lesions
and extract data. The data are then analyzed utilizing imaging processing
classification algorithms, trained on our proprietary database of melanomas
and benign lesions, to provide information to assist in the management of
the patient, including information useful in the decision of whether to
biopsy the lesion.
Melanoma is the deadliest of skin cancers, responsible for approximately
80% of all skin cancer deaths. Unless melanoma is detected early and
excised with proper margins, the patient survival rate is poor, as there is
currently no cure for advanced stage melanoma.
For more information on EOS, visit www.eosciences.com.
Safe Harbor
This press release includes "forward-looking statements" within the meaning
of the Securities Litigation Reform Act of 1995. These statements include
but are not limited to our plans, objectives, expectations and intentions
and other statements that contain words such as "expects," "contemplates,"
"anticipates," "plans," "intends," "believes" and variations of such words
or similar expressions that predict or indicate future events or trends, or
that do not relate to historical matters. These statements are based on our
current beliefs or expectations and are inherently subject to significant
uncertainties and changes in circumstances, many of which are beyond our
control. There can be no assurance that our beliefs or expectations will be
achieved. Actual results may differ materially from our beliefs or
expectations due to economic, business, competitive, market and regulatory
factors.